Gene transfer into haematopoietic stem cells for the treatment of ADA-deficient SCID

被引：0

作者：

Aiuti, A

Benninghoff, U

Cassani, B

Cattaneo, F

Andolfi, G

Mirolo, M

Callegaro, L

Tabucchi, A

Carlucci, F

Eibl, M

Aker, M

Slavin, S

Miniero, R

Roncarolo, M

San Raffaele, CB

机构：

[1] San Raffaele Telethon Inst Gene Therapy, HSR, TIGET, Milan, Italy

[2] Univ Siena, I-53100 Siena, Italy

[3] Immunol Tagesklin, Vienna, Austria

[4] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel

来源：

BONE MARROW TRANSPLANTATION | 2005年 / 35卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S17 / S17

页数：1

共 50 条

[31] Development of gene therapy for blood disorders by gene transfer into haematopoietic stem cells
Karlsson, S
Ooka, A
Woods, NB
HAEMOPHILIA, 2002, 8 (03) : 255 - 260
[32] Rescue of mouse Prkdc scid deficiency by transplantation of gene-repaired haematopoietic stem cells
Abdul-Razak, Hayder H.
Rocca, Celine
Howe, Steven J.
Eugenia Alonso-Ferrero, Maria
Gabriel, Richard
Bartholomae, Cynthia C.
Gan, Chih Hao Victor
Garin, Marina
Javier Molina-Estevez, Francisco
Roberts, Alison C.
Blundell, Michael
Gueenechea, Guillermo
Holmes, Michael C.
Gregory, Philip D.
Kinnon, Christine
von Kalle, Christof
Schmidt, Manfred
Bueren, Juan A.
Thrasher, Adrian J.
Yanez-Munoz, Rafael J.
HUMAN GENE THERAPY, 2013, 24 (05) : A6 - A7
[33] Canine fucosidosis: a model for retroviral gene transfer into haematopoietic stem cells
Ferrara, ML
Occhiodoro, T
Fuller, M
Hawthorne, WJ
Teutsch, S
Tucker, VE
Hopwood, JJ
Stewart, GJ
Anson, DS
NEUROMUSCULAR DISORDERS, 1997, 7 (05) : 361 - 366
[34] Dosing and Re-Administration of Intravenous Lentiviral Vector for Liver-Directed Gene Transfer in Young Rhesus Monkeys and ADA-Deficient Mice
Carbonaro-Sarracino, Denise A.
Tarantal, Alice F.
Lee, Chang I.
Kaufman, Michael L.
Martinez, Michele
Clark, Danielle N.
Koziol, Colin
Kohn, Donald B.
MOLECULAR THERAPY, 2016, 24 : S302 - S303
[35] Safety and efficacy of stem cell gene therapy combined with nonmyeloablative conditioning for the treatment of ADA-SCID.
Aiuti, A
Cattaneo, F
Cassani, B
Andolfi, G
Ficara, F
Mirolo, M
Tabucchi, A
Carlucci, F
Gaetaniello, L
Miniero, R
Aker, M
Slavin, S
Roncarolo, MG
Bordignon, C
BLOOD, 2003, 102 (11) : 154A - 154A
[36] Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreduction
Carbonaro, Denise A.
Jin, Xiangyang
Wang, Xingchao
Yu, Xiao-Jin
Rozengurt, Nora
Kaufman, Michael L.
Wang, Xiaoyan
Gjertson, David
Zhou, Yang
Blackburn, Michael R.
Kohn, Donald B.
BLOOD, 2012, 120 (18) : 3677 - 3687
[37] Dosing and Re-Administration of Lentiviral Vector for In Vivo Gene Therapy in Rhesus Monkeys and ADA-Deficient Mice
Carbonaro-Sarracino, Denise A.
Tarantal, Alice F.
Lee, C. Chang, I
Kaufman, Michael L.
Wandro, Stephen
Jin, Xiangyang
Martinez, Michele
Clark, Danielle N.
Chun, Krista
Koziol, Colin
Hardee, Cinnamon L.
Wang, Xiaoyan
Kohn, Donald B.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 16 : 78 - 93
[38] Flow Cytometry analysis of adenosine deaminase (ADA) expression: A simple and reliable tool for the assessment of ADA-deficient patients before and after gene therapy
Otsu, M
Hershfield, MS
Tuschong, LM
Muul, LM
Onodera, M
Ariga, T
Sakiyama, Y
Candotti, F
HUMAN GENE THERAPY, 2002, 13 (03) : 425 - 432
[39] GENE-THERAPY FOR NEONATES WITH ADENOSINE-DEAMINASE (ADA) DEFICIENT SCID BY RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34+ CELLS
KOHN, DB
WEINBERG, KI
LENARSKY, C
CROOKS, GM
HANLEY, ME
LAWRENCE, K
ANNETT, G
BROOKS, JS
WARA, D
ELDER, M
WILLIAMSHERMAN, D
BOWEN, T
HERSHFIELD, MS
BERENSON, RI
MOEN, RC
MULLEN, CA
BLAESE, RM
PARKMAN, R
PEDIATRIC RESEARCH, 1994, 35 (04) : A152 - A152
[40] Gene Editing in Human Haematopoietic Stem Cells for the Treatment of Primary Immunodeficiencies
Sameer Bahal
Klesti Karaxhuku
Giorgia Santilli
Molecular Diagnosis & Therapy, 2023, 27 : 15 - 28

← 1 2 3 4 5 →